JBIO Financials

Income Statement
MetricQ2 2026Q1 2026Q3 2025Q2 2025
Revenue
0
0
0
0
Cost of Revenue
0
0
0
0
Gross Profit
0
0
0
0
Operating Expenses
58.9M
+35.6%
43.4M
+58.6%
27.4M
-1.4%
27.8M
R&D
50.1M
+38.9%
36.1M
+63.8%
22.0M
-2.4%
22.5M
SG&A
8.9M
+19.7%
7.4M
+37.1%
5.4M
+3.1%
5.2M
Operating Income
-58916000
-35.6%
-43445000
-58.6%
-27401000
+1.4%
-27778000
EBITDA
-58907000
-35.6%
-43436000
-58.6%
-27389000
+1.4%
-27773000
Net Income
-55765000
-38.1%
-40368000
-60.3%
-25175000
+21.7%
-32134000
EPS (Basic)
$-0.76
-33.3%
$-0.57
-18.7%
$-0.48
+44.2%
$-0.86
EPS (Diluted)
$-0.76
-33.3%
$-0.57
-18.7%
$-0.48
+44.2%
$-0.86
Shares (Diluted)
61.1M
+5.7%
57.8M
+46.0%
39.6M
+39.2%
28.4M
Jade Biosciences (JBIO) โ€” Financials